MediPoint: Bone Growth Stimulators - Europe Analysis and Market Forecasts

MediPoint: Bone Growth Stimulators - Europe Analysis and Market Forecasts

Summary

European bone growth stimulator market was estimated at $101.6M in 2016 across the 21 markets (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and UK) covered in this report.

Key drivers of the bone growth stimulator market in the forecast period are -

Growing elderly population and subsequent rise in fracture incidence, osteoporosis, and spinal disease

Rising patient awareness of the availability and benefits of stimulation treatments

Continued research into the efficacy of bone growth stimulators, resulting in improved reimbursement scenarios

Electrical stimulation using bone growth stimulators has long been considered a viable treatment option for fracture non-unions, failed unions, and failed spinal fusions. However, the efficacy of these devices is not well established, and potential patient benefit through their use on fresh fractures is currently under investigation. Continued research on these devices is necessary to grow the market, as positive data will precipitate a more favorable reimbursement scenario, thus increasing physician and patient adoption.

The European bone growth stimulators market is projected to grow at a CAGR of 2.1% during the forecast period. Germany represented the largest portion of the market in 2016, holding 30.1% of the regional revenue, and is expected to maintain this dominance through the forecast period. Finland is expected to be the fastest-growing market through 2023, at a CAGR of 3.8%, while the slowest growth will be observed in Austria at a CAGR of 0.8%.

The report MediPoint: Bone Growth Stimulators - Europe Analysis and Market Forecasts focuses on the market outlook for bone growth stimulator devices in Europe (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and UK).

In particular, this report allows the following analysis -

Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the European bone growth stimulator market. Insightful review of the key industry drivers, barriers, and challenges.

Companies mentioned in this report: Bioventus, DJO Global, IGEA, Orthofix, Zimmer Biomet.

Scope

• Overview of recent key industry events and analysis of their market impact.
• Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.
• Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.
• Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
• Analysis of the current and future market competition in the European bone growth stimulator market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.